CTOs on the Move

PredictSpring

www.predictspring.com

 
Founded by the visionary behind Google Shopping and early mobile commerce pioneers from VISA and Motorola, PredictSpring is revolutionizing omni-channel commerce with an innovative technology platform that helps consumers shop anywhere, anytime with a single touch of a button. PredictSpring Mobile Platform provides a seamless shopping experience by bringing the best of mobile technology to consumer and store associate apps. PredictSpring powers the mobile experience for the world`s leading retailers and brands, including Calvin Klein, Cole Haan, Forever New, Woodcraft, Eddie Bauer, Nine West, New York & Company, Claire`s and Vineyard Vines.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

PredictSpring raised $11.4M on 06/28/2016
PredictSpring raised $16M on 06/15/2022

Similar Companies

Electronic Knowledge Interchange

Electronic Knowledge Interchange is a Chicago, IL-based company in the Software and Internet sector.

Virterra

Virterra is a Waltham, MA-based company in the Software and Internet sector.

Ryan Matthews Agency

Ryan Matthews Agency is a Las Vegas, NV-based company in the Software and Internet sector.

Proofspace

Proofspace, Inc is a Grand Rapids, MI-based company in the Software and Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.